*The following content is generated by AI and is for reference only.
<h3>Overview</h3>
<p>Empagliflozin R-Furanoes refers to the specific furanose stereoisomer of the SGLT2 inhibitor Empagliflozin. This chiral intermediate is critical for high-purity API synthesis via asymmetric catalysis or enzymatic resolution. The core structure features a distinct <strong>R-configuration</strong> at the furanose ring, ensuring optimal pharmacological activity. Molecular formula: C20H25ClO6; CAS No.: 864074-69-1 (for the specific isomer).</p>
<h3>Application</h3>
<ul>
<li><strong>Pharmaceutical Manufacturing</strong>: Primary building block for synthesizing Empagliflozin sodium tablets targeting Type 2 Diabetes.</li>
<li><strong>Quality Control Labs</strong>: Used as reference standards for HPLC method validation and impurity profiling.</li>
<li><strong>Clinical Research</strong>: Essential for studying stereochemical influences on renal glucose reabsorption inhibition.</li>
</ul>
<h3>Precautions</h3>
<p>Strictly store under inert atmosphere at -20°C to prevent racemization. Handle with PPE due to potential sensitization; avoid inhalation of dust. Clinical use requires monitoring for euglycemic ketoacidosis in susceptible populations.</p>